Gasterin,P40,PAX8,Fumerate Hydrase,NKX3 dot1,CDK4,CK5and6
All India Institute Of Medical Sciences (aiims)
SOUTH DELHI, DELHI
Progress
Quantity
899
Category
Beta HCG
Bid Type
Two Packet Bid
The New Civil Hospital, under the Health & Family Welfare Department Gujarat, invites bids for pathology lab reagents and immunohistochemistry (IHC) supplies to support diagnostic capabilities at Surat, Gujarat 394101. The procurement scope encompasses a broad catalog of items including monoclonal and polyclonal antibodies (CD markers, CKs, PDL1, ERG, GATA3, SOX10, SMA, TTF-1, etc.), DAB detection kits, retrieval solutions, stains, and related IHC consumables. The BOQ contains 167 line items, signaling a wide-order requirement for reagents, slides, buffers, and auxiliary equipment. A key differentiator is the extensive antibody and kit portfolio spanning multiple diagnostic targets, requiring strict quality conformity and compatibility with IS IHC workflows. This tender aligns with government procurement for continued pathology services in Surat.
167-item BOQ covering pathology reagents and IHC supplies
Includes antibodies for CD markers, CK panels, LCA, PDL1, SOX10, GATA3, TTF-1, MUC1/2/4, HER2, CA 125, CA 19-9, CEA variants
DAB detection kits and Envision HRP reagents
Staining buffers, retrieval solutions, charged slides, and related consumables
No explicit quantitative specs provided in available data; verify quantities and exact list in the official BOQ
25% quantity variation allowed at contract execution
Extended delivery period to be calculated with minimum 30 days
Delivery/fulfillment aligned to last date of original delivery order
EMD, GST, PAN, and OEM authorizations required as part of bid
167-item BOQ with unspecified exact quantities
ATC indicates bidder compliance with supplier terms and conditions
Payment terms not explicitly stated; verify with ATC. Expect standard government terms and potential advance/ milestone payments per contract.
Delivery period governed by option clause; extended delivery time calculated as (Increased quantity ÷ Original quantity) × Original delivery period, minimum 30 days.
Not specified in provided data; confirm LD/penalty terms in ATC and contract; ensure compliance with delivery commitments.
Proven experience in supplying pathology reagents or IHC kits
GST registration and financial stability evidenced by financial statements
OEM authorization or authorized distributor status for major reagents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
All India Institute Of Medical Sciences (aiims)
SOUTH DELHI, DELHI
All India Institute Of Medical Sciences (aiims)
SOUTH DELHI, DELHI
Regional Institute Of Paramedical & Nursing Sciences(ripans)
AIZAWL, MIZORAM
Indian Army
ALLAHABAD, UTTAR PRADESH
Indian Council Of Medical Research (icmr)
MUMBAI, MAHARASHTRA
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | ALK 1 | Marker for ALK positive anaplastic large cell lymphoma and other ALK rearranged malignancies | 1 | bottel | srclerk1_vipul | 15 |
| 2 | Alpha Feto Protein | Marker for hepatocellular carcinoma and germ cell tumours | 1 | bottel | srclerk1_vipul | 15 |
| 3 | Alpha methyacyl CoA Racemase AMACR | Marker for prostate carcinoma and other cancers | 1 | bottel | srclerk1_vipul | 15 |
| 4 | Arginase 1 | Marker for hepatocellular differentiation | 1 | bottel | srclerk1_vipul | 15 |
| 5 | Bcl 2 | Anti apoptotic marker used in lymphomas and other malignancies | 1 | bottel | srclerk1_vipul | 15 |
| 6 | Bcl 6 | Marker for follicular lymphomas and other B cell malignancies | 1 | bottel | srclerk1_vipul | 15 |
| 7 | Ber EP 4 | Marker for epithelial origin tumours | 1 | bottel | srclerk1_vipul | 15 |
| 8 | Beta Catenin | Marker for Want signalling pathway used in colon and other carcinomas | 1 | bottel | srclerk1_vipul | 15 |
| 9 | Beta HCG | Marker for trophoblastic tumours and some germ cell tumours | 1 | bottel | srclerk1_vipul | 15 |
| 10 | Bond Solution APES | Adhesive solution for coating slides in immunohistochemistry | 1 | bottel | srclerk1_vipul | 15 |
| 11 | Brachyury | Marker for chordoma and other tumours | 1 | bottel | srclerk1_vipul | 15 |
| 12 | CA 125 | Marker for ovarian carcinoma | 1 | bottel | srclerk1_vipul | 15 |
| 13 | CA 19 9 | Marker for pancreatic and gastrointestinal malignancies | 1 | bottel | srclerk1_vipul | 15 |
| 14 | Calcitonin | Marker for medullary thyroid carcinoma | 1 | bottel | srclerk1_vipul | 15 |
| 15 | Calretinin | Marker for mesothelioma and other tumours | 1 | bottel | srclerk1_vipul | 15 |
| 16 | Caldesmon | Marker for smooth muscle differentiation | 1 | bottel | srclerk1_vipul | 15 |
| 17 | Cam 5 2 | Cytokeratin marker for epithelial tissues | 1 | bottel | srclerk1_vipul | 15 |
| 18 | CD1a | Marker for Langerhans cell histiocytosis | 1 | bottel | srclerk1_vipul | 15 |
| 19 | Sox 9 | Marker for Cartilege Tummer | 1 | bottel | srclerk1_vipul | 15 |
| 20 | CD3 | T cell marker used in lymphoma diagnostics | 1 | bottel | srclerk1_vipul | 15 |
| 21 | CD5 | Marker for T cell and some B cell lymphomas | 1 | bottel | srclerk1_vipul | 15 |
| 22 | CD10 | Marker for follicular lymphoma and other malignancies | 1 | bottel | srclerk1_vipul | 15 |
| 23 | CD14 | Marker for monocyte macrophage lineage | 1 | bottel | srclerk1_vipul | 15 |
| 24 | CD15 | Marker for Hodgkin lymphoma and other malignancies | 1 | bottel | srclerk1_vipul | 15 |
| 25 | CD19 | B cell marker used in leukaemia and lymphoma diagnostics | 1 | bottel | srclerk1_vipul | 15 |
| 26 | CD20 | B cell marker for lymphomas and leukaemia s | 1 | bottel | srclerk1_vipul | 15 |
| 27 | CD21 | Marker for follicular dendritic cells | 1 | bottel | srclerk1_vipul | 15 |
| 28 | CD23 | Marker for chronic lymphocytic leukaemia and follicular dendritic cells | 1 | bottel | srclerk1_vipul | 15 |
| 29 | CD30 | Marker for Hodgkin lymphoma and anaplastic large cell lymphoma | 1 | bottel | srclerk1_vipul | 15 |
| 30 | CD31 | Marker for vascular endothelium | 1 | bottel | srclerk1_vipul | 15 |
| 31 | CD34 | Marker for hematopoietic stem cells and vascular endothelium | 1 | bottel | srclerk1_vipul | 15 |
| 32 | CD38 | Marker for plasma cells and B cell differentiation | 1 | bottel | srclerk1_vipul | 15 |
| 33 | CD41 | Marker for platelet precursors | 1 | bottel | srclerk1_vipul | 15 |
| 34 | CD45 LCA | Leukocyte common antigen marker for hematopoietic cells | 1 | bottel | srclerk1_vipul | 15 |
| 35 | CD56 | Marker for NK cells and neural neuroendocrine tumours | 1 | bottel | srclerk1_vipul | 15 |
| 36 | CD61 | Marker for megakaryocytes and platelets | 1 | bottel | srclerk1_vipul | 15 |
| 37 | CD68 | Marker for macrophages | 1 | bottel | srclerk1_vipul | 15 |
| 38 | CD79a | Marker for B cell lineage | 1 | bottel | srclerk1_vipul | 15 |
| 39 | CD99 | Marker for Ewing sarcoma and other small round cell tumours | 1 | bottel | srclerk1_vipul | 15 |
| 40 | CD117 | Marker for gastrointestinal stromal tumours GIST | 1 | bottel | srclerk1_vipul | 15 |
| 41 | CD138 | Marker for plasma cells | 1 | bottel | srclerk1_vipul | 15 |
| 42 | CDX 2 | Marker for gastrointestinal origin tumours | 1 | bottel | srclerk1_vipul | 15 |
| 43 | CDK4 | Marker for cell cycle regulation used in sarcomas | 1 | bottel | srclerk1_vipul | 15 |
| 44 | CDH17 | Marker for gastrointestinal tract differentiation | 1 | bottel | srclerk1_vipul | 15 |
| 45 | CEA Monoclonal | Marker for colorectal and other adenocarcinomas | 1 | bottel | srclerk1_vipul | 15 |
| 46 | CEA Polyclonal | Marker for colorectal and other adenocarcinomas | 1 | bottel | srclerk1_vipul | 15 |
| 47 | Chromogranin A | Marker for neuroendocrine tumours | 1 | bottel | srclerk1_vipul | 15 |
| 48 | CK5 6 | Cytokeratin marker for basal and squamous cell differentiation | 1 | bottel | srclerk1_vipul | 15 |
| 49 | CK7 | Cytokeratin marker for epithelial origin | 1 | bottel | srclerk1_vipul | 15 |
| 50 | CK14 | Marker for squamous cell differentiation | 1 | bottel | srclerk1_vipul | 15 |
| 51 | CK8 | Marker for simple epithelia | 1 | bottel | srclerk1_vipul | 15 |
| 52 | CK8 18 | Marker for epithelial differentiation | 1 | bottel | srclerk1_vipul | 15 |
| 53 | CK19 | Marker for colorectal and urothelial carcinoma | 1 | bottel | srclerk1_vipul | 15 |
| 54 | CK20 | Marker for colorectal and urothelial carcinoma | 1 | bottel | srclerk1_vipul | 15 |
| 55 | CK AE1 AE3 | Pan cytokeratin marker for epithelial origin tumours | 1 | bottel | srclerk1_vipul | 15 |
| 56 | Claudin 4 | Marker for epithelial tight junctions useful in distinguishing adenocarcinomas from mesotheliomas | 1 | bottel | srclerk1_vipul | 15 |
| 57 | Collagen IV | Marker for basement membrane integrity | 1 | bottel | srclerk1_vipul | 15 |
| 58 | Cyclin D1 | Marker for cell cycle regulation used in mantle cell lymphoma and other cancers | 1 | bottel | srclerk1_vipul | 15 |
| 59 | DAB Reagent | Chromogen reagent for visualization in IHC | 1 | bottel | srclerk1_vipul | 15 |
| 60 | Desmin | Marker for muscle differentiation | 1 | bottel | srclerk1_vipul | 15 |
| 61 | DOG1 | Marker for gastrointestinal stromal tumours GIST | 1 | bottel | srclerk1_vipul | 15 |
| 62 | E cadherin NCH 38 | Marker for epithelial cell adhesion used in differentiating carcinomas | 1 | bottel | srclerk1_vipul | 15 |
| 63 | EGFR | Marker for epidermal growth factor receptor associated with various cancers | 1 | bottel | srclerk1_vipul | 15 |
| 64 | EBV | Marker for Epstein Barr virus associated malignancies | 1 | bottel | srclerk1_vipul | 15 |
| 65 | EMA | Marker for epithelial membrane antigen used in carcinomas and other epithelial tumours | 1 | bottel | srclerk1_vipul | 15 |
| 66 | ER | Estrogen receptor marker used in breast and other hormone sensitive cancers | 1 | bottel | srclerk1_vipul | 15 |
| 67 | FOX L2 | Marker for granulosa cell tumours | 1 | bottel | srclerk1_vipul | 15 |
| 68 | GCDFP 15 | Marker for apocrine differentiation used in breast and salivary gland tumours | 1 | bottel | srclerk1_vipul | 15 |
| 69 | Glypican 3 | Marker for hepatocellular carcinoma | 1 | bottel | srclerk1_vipul | 15 |
| 70 | GATA 3 | Marker for breast and urothelial carcinomas | 1 | bottel | srclerk1_vipul | 15 |
| 71 | GFAP | Marker for astrocytes and glial cells | 1 | bottel | srclerk1_vipul | 15 |
| 72 | Hep Par 1 | Marker for hepatocellular differentiation | 1 | bottel | srclerk1_vipul | 15 |
| 73 | Her 2 neu | Marker for HER2 overexpression in breast and other cancers | 1 | bottel | srclerk1_vipul | 15 |
| 74 | HMB 45 | Marker for melanoma | 1 | bottel | srclerk1_vipul | 15 |
| 75 | HMW CK 34 E12 | High molecular weight cytokeratin marker for basal and squamous cell differentiation | 1 | bottel | srclerk1_vipul | 15 |
| 76 | Inhibin alpha | Marker for sex cord stromal tumours | 1 | bottel | srclerk1_vipul | 15 |
| 77 | INI1 | Marker for rhabdoid tumours and other malignancies | 1 | bottel | srclerk1_vipul | 15 |
| 78 | Kappa light chain | Marker for monoclonal B cell populations | 1 | bottel | srclerk1_vipul | 15 |
| 79 | Ki 67 | Proliferation marker used in grading malignancies | 1 | bottel | srclerk1_vipul | 15 |
| 80 | Lambda light chain | Marker for monoclonal B cell populations | 1 | bottel | srclerk1_vipul | 15 |
| 81 | Langerin | Marker for Langerhans cell histiocytosis | 1 | bottel | srclerk1_vipul | 15 |
| 82 | LIN28A | Marker for embryonal tumours | 1 | bottel | srclerk1_vipul | 15 |
| 83 | MPO Poluclonal | Marker for myeloid lineage used in leukaemia diagnostics | 1 | bottel | srclerk1_vipul | 15 |
| 84 | MSA Muscle Specific Actin | Marker for smooth muscle differentiation | 1 | bottel | srclerk1_vipul | 15 |
| 85 | Melan A | Marker for melanocytic tumours | 1 | bottel | srclerk1_vipul | 15 |
| 86 | MDM2 | Marker for liposarcoma and other malignancies | 1 | bottel | srclerk1_vipul | 15 |
| 87 | MLH1 | Marker for mismatch repair deficiency in tumours | 1 | bottel | srclerk1_vipul | 15 |
| 88 | MSH2 | Marker for mismatch repair deficiency in tumours | 1 | bottel | srclerk1_vipul | 15 |
| 89 | MSH6 | Marker for mismatch repair deficiency in tumours | 1 | bottel | srclerk1_vipul | 15 |
| 90 | Mammaglobin | Marker for breast carcinoma | 1 | bottel | srclerk1_vipul | 15 |
| 91 | MOC31 | Marker for epithelial tumours particularly carcinomas | 1 | bottel | srclerk1_vipul | 15 |
| 92 | MIB1 | Proliferation marker synonymous with Ki 67 | 1 | bottel | srclerk1_vipul | 15 |
| 93 | MUC1 | Marker for glandular epithelium and adenocarcinomas | 1 | bottel | srclerk1_vipul | 15 |
| 94 | MUC2 | Marker for goblet cells and mucinous tumours | 1 | bottel | srclerk1_vipul | 15 |
| 95 | MUC4 | Marker for certain adenocarcinomas including pancreas and lung | 1 | bottel | srclerk1_vipul | 15 |
| 96 | MUM1 | Marker for multiple myeloma and diffuse large B cell lymphoma | 1 | bottel | srclerk1_vipul | 15 |
| 97 | Myogenin | Marker for rhabdomyosarcoma | 1 | bottel | srclerk1_vipul | 15 |
| 98 | Novapen Pap pen Hydrophobic Slide Marker | Used for hydrophobic barrier creation on slides | 1 | bottel | srclerk1_vipul | 15 |
| 99 | Napsin A | Marker for lung adenocarcinoma | 1 | bottel | srclerk1_vipul | 15 |
| 100 | NANOG | Stem cell marker used in embryonal tumours | 1 | bottel | srclerk1_vipul | 15 |
| 101 | NUT | Marker for NUT midline carcinoma | 1 | bottel | srclerk1_vipul | 15 |
| 102 | NKX2 2 | Marker for Ewing sarcoma | 1 | bottel | srclerk1_vipul | 15 |
| 103 | NSE | Marker for neural and neuroendocrine differentiation | 1 | bottel | srclerk1_vipul | 15 |
| 104 | OCT 3 4 | Marker for embryonic stem cells and germ cell tumours | 1 | bottel | srclerk1_vipul | 15 |
| 105 | p16 | Tumour suppressor marker associated with HPV related cancers | 1 | bottel | srclerk1_vipul | 15 |
| 106 | p40 | Marker for squamous cell differentiation used in lung and head neck cancers | 1 | bottel | srclerk1_vipul | 15 |
| 107 | p53 | Tumour suppressor marker mutated in many cancers | 1 | bottel | srclerk1_vipul | 15 |
| 108 | p57 | Marker for trophoblastic diseases | 1 | bottel | srclerk1_vipul | 15 |
| 109 | p63 | Marker for squamous epithelium and myoepithelial cells | 1 | bottel | srclerk1_vipul | 15 |
| 110 | Placental Alkaline Phosphatase PLAP | Marker for germ cell tumours | 1 | bottel | srclerk1_vipul | 15 |
| 111 | PR | Progesterone receptor marker used in breast and endometrial cancers | 1 | bottel | srclerk1_vipul | 15 |
| 112 | Pax2 | Marker for renal and Mullerian origin tumours | 1 | bottel | srclerk1_vipul | 15 |
| 113 | Pax5 | Marker for B cell lineage used in lymphomas | 1 | bottel | srclerk1_vipul | 15 |
| 114 | Pax8 | Marker for renal thyroid and Mullerian origin tumours | 1 | bottel | srclerk1_vipul | 15 |
| 115 | Poly L Lysine | Coating agent for adhesion of tissue sections to slides | 1 | bottel | srclerk1_vipul | 15 |
| 116 | PSA | Marker for prostate specific antigen used in prostate cancer | 1 | bottel | srclerk1_vipul | 15 |
| 117 | PLAG1 | Marker for pleomorphic adenomas and related tumours | 1 | bottel | srclerk1_vipul | 15 |
| 118 | PMS2 | Marker for mismatch repair deficiency in tumours | 1 | bottel | srclerk1_vipul | 15 |
| 119 | SALL4 | Marker for germ cell tumours and embryonal tumours | 1 | bottel | srclerk1_vipul | 15 |
| 120 | SATB2 | Marker for colorectal cancer and other carcinomas | 1 | bottel | srclerk1_vipul | 15 |
| 121 | SF1 | Marker used in steroid hormone synthesis | 1 | bottel | srclerk1_vipul | 15 |
| 122 | SOX2 | Stem cell marker used in embryonic development and cancers | 1 | bottel | srclerk1_vipul | 15 |
| 123 | SOX10 | Marker for neural crest and melanocytic tumours | 1 | bottel | srclerk1_vipul | 15 |
| 124 | SMURF1 | Regulator of TGF beta signalling pathways | 1 | bottel | srclerk1_vipul | 15 |
| 125 | STAT 6 | Marker for IL 4 IL 13 mediated immune signalling | 1 | bottel | srclerk1_vipul | 15 |
| 126 | S 100 | Marker for melanoma and other neural neuroendocrine tumours | 1 | bottel | srclerk1_vipul | 15 |
| 127 | Secondary Kit New and Improved Super Sensitive Polymer HRP IHC Detection Kit 1St Generation | Includes 40ml H2O2 40ml HRP 40ml mouse linker 80ml DAB substrate buffer 2ml Chromogen 30ml x 3 Antigen retrieval solution concentrate 1L washing buffer concentrate 1St Generation | 1 | bottel | srclerk1_vipul | 15 |
| 128 | Secondary Kit New and Improved Super Sensitive Polymer HRP IHC Detection Kit 2nd Generation | Includes 40ml H2O2 40ml HRP 40ml mouse linker 80ml DAB substrate buffer 2ml Chromogen 30ml x 3 Antigen retrieval solution concentrate 1L washing buffer concentrate 2ND Generation | 1 | bottel | srclerk1_vipul | 15 |
| 129 | Secondary Kit New and Improved Super Sensitive Polymer HRP IHC Detection Kit 3rd Generation | Includes 40ml H2O2 40ml HRP 40ml mouse linker 80ml DAB substrate buffer 2ml Chromogen 30ml x 3 Antigen retrieval solution concentrate 1L washing buffer concentrate 3RD Generation | 1 | bottel | srclerk1_vipul | 15 |
| 130 | SMA | Smooth muscle actin marker used in mesenchymal and myogenic tumours | 1 | bottel | srclerk1_vipul | 15 |
| 131 | Smoothelin | Smooth muscle differentiation marker | 1 | bottel | srclerk1_vipul | 15 |
| 132 | Synaptophysin | Marker for neuroendocrine and neural differentiation | 1 | bottel | srclerk1_vipul | 15 |
| 133 | Tdt | Terminal deoxynucleotidyl transferase used in lymphoblastic leukaemia lymphoma | 1 | bottel | srclerk1_vipul | 15 |
| 134 | TFE 3 | Marker for transcription factor in specific cancers such as renal cell carcinoma | 1 | bottel | srclerk1_vipul | 15 |
| 135 | TLE 1 | Marker for synovial sarcoma | 1 | bottel | srclerk1_vipul | 15 |
| 136 | TTF 1 | Marker for thyroid and lung carcinomas | 1 | bottel | srclerk1_vipul | 15 |
| 137 | Vimentin | Marker for mesenchymal origin tumours | 1 | bottel | srclerk1_vipul | 15 |
| 138 | WT 1 | Marker for Wilms tumour and other cancers | 1 | bottel | srclerk1_vipul | 15 |
| 139 | Uroplakin 2 | Marker for urothelial differentiation | 1 | bottel | srclerk1_vipul | 15 |
| 140 | Uroplakin 3 | Marker for urothelial carcinoma | 1 | bottel | srclerk1_vipul | 15 |
| 141 | Wash Buffer | Concentrated solution for washing in IHC | 1 | bottel | srclerk1_vipul | 15 |
| 142 | Retrieval Solution | Solution for antigen retrieval during IHC | 1 | bottel | srclerk1_vipul | 15 |
| 143 | Rabbit Linker | Polymer linker for rabbit antibodies in IHC | 1 | bottel | srclerk1_vipul | 15 |
| 144 | Mouse Linker | Polymer linker for Mouse antibodies in IHC | 1 | bottel | srclerk1_vipul | 15 |
| 145 | Envision FLEX HRP | flex hrp magenta substrate chromogen system | 1 | bottel | srclerk1_vipul | 15 |
| 146 | Peroxidase Blocking Reagent | a highly stable form of hydrogen peroxide for blocking endogenous peroxidase | 1 | bottel | srclerk1_vipul | 15 |
| 147 | Substrate Buffer | Widely used in biochemical assays especially when alkaline phosphatase activity is to be measured | 1 | bottel | srclerk1_vipul | 15 |
| 148 | DAB plus Chromogen | as per discription in specification | 1 | bottel | srclerk1_vipul | 15 |
| 149 | IDH m and wild Type | IDH mutation in glioma has a unique effect on DNA methylome and transcriptome | 1 | bottel | srclerk1_vipul | 15 |
| 150 | oct 0 2 | Octamer Binding Transcription Factor 2 OCT2 | 1 | bottel | srclerk1_vipul | 15 |
| 151 | Atrx | define the molecular classification of gliomas | 1 | bottel | srclerk1_vipul | 15 |
| 152 | Digital pH Meter | Instrument for measuring pH accurately | 1 | bottel | srclerk1_vipul | 15 |
| 153 | Haematoxylin Stain | Nuclear stain for tissue sections | 135 | bottel | srclerk1_vipul | 15 |
| 154 | PD L1 IHC 22C3 pharmDx | Specific assay for detecting PD L1 in cancer tissues | 1 | bottel | srclerk1_vipul | 15 |
| 155 | Charged Slides | Positively charged slides for tissue adhesion | 500 | nos | srclerk1_vipul | 15 |
| 156 | Diamond Marker Pen | Marker for writing on slides | 1 | bottel | srclerk1_vipul | 15 |
| 157 | Retrieval Chamber | Chamber for controlled heat based antigen retrieval | 1 | bottel | srclerk1_vipul | 15 |
| 158 | Humidity Chamber | Chamber for maintaining optimal humidity during staining | 1 | bottel | srclerk1_vipul | 15 |
| 159 | Polished Tissue Embedding Molds | as per discription in specification | 1 | bottel | srclerk1_vipul | 15 |
| 160 | Glass Slide Staining Rack Dual Clamp | as per discription in specification | 1 | bottel | srclerk1_vipul | 15 |
| 161 | Electronic Pressure Cooker Induction | Used for high pressure heat mediated antigen retrieval | 1 | bottel | srclerk1_vipul | 15 |
| 162 | Antibody Diluent | Buffer to dilute antibodies for IHC | 1 | bottel | srclerk1_vipul | 15 |
| 163 | Coated Slides | Pre treated slides for IHC applications | 100 | nos | srclerk1_vipul | 15 |
| 164 | BSAP Pax 5 | PAX 5 in an immunohistochemical panel to diagnose lymphoid neoplasms of B cell origin | 1 | bottel | srclerk1_vipul | 15 |
| 165 | Cytok HMW 38 E12 | antibody promises to be a specific marker useful in differential identification of squamous carcinomas from adenocarcinomas | 1 | bottel | srclerk1_vipul | 15 |
| 166 | ERG EP110 | ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic | 1 | bottel | srclerk1_vipul | 15 |
| 167 | NKX3 1 | highly sensitive and specific tissue marker of metastatic prostatic adenocarcinoma | 1 | bottel | srclerk1_vipul | 15 |
Discover companies most likely to bid on this tender
GST registration certificate
Permanent Account Number (PAN) card
Experience certificates for similar pathology/ IHC reagent supply
Financial statements (audited or CA-certified)
Bid security/EMD documentation as per ATC
Technical bid documents and product compliance certificates
OEM authorizations or authorized distributor letters
Any IS/ISO conformity certificates relevant to IHC reagents
Key insights about GUJARAT tender market
Bidders should submit GST, PAN, experience proofs, financials, EMD, technical bid, OEM authorizations, and product compliance certificates as per ATC. Ensure 167-item BOQ items are reviewed and comply with IHC reagent standards; delivery timing follows the option clause with a 30-day minimum extension.
Submit GST certificate, PAN, at least one experience certificate for similar supply, audited financials, EMD proof, OEM authorization, technical bid, and any IS/ISO conformity certificates applicable to IHC reagents used in pathology labs.
The tender includes monoclonal and polyclonal antibodies targeting CD markers, CK panels, LCA, SOX10, PD-L1, GATA3, CK/CK8/18, TTF-1, MUC family, HER2, PAX8, PAX2, and related IHC reagents; explicit quantitative specs are not disclosed publicly and must be confirmed in the BOQ.
Delivery timing follows the option clause; quantity changes up to 25% are allowed, and extra time is calculated as (Increased quantity ÷ Original quantity) × Original delivery period, with a minimum of 30 days.
BOQ comprises 167 line items spanning antibodies, DAB kits, retrieval solutions, buffers, slides, stains, and related IHC consumables; exact quantities are not disclosed online and must be retrieved from the official bid documents.
Bidders should provide OEM authorizations and certifications for reagents (e.g., IS/ISO compatibility where applicable) and ensure reagents are suitable for Envision HRP detection workflows specified in the tender catalog.
EMD details are not disclosed in the available data; bidders must refer to the tender ATC for exact EMD amounts. Payment terms typically align with government procurement norms; confirm on submission and contract award.
Obtain an OEM authorization letter from the reagent manufacturer or an authorized distributor, clearly identifying product lines included in the 167-item BOQ; attach with technical bid to demonstrate supply eligibility.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS